

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61109473 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61109473 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.58985660 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.43755674 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18527547 |
| 6 | cellular extravasation (GO:0045123) | 4.15709853 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10728496 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.10728496 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10728496 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10728496 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10728496 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.10728496 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.04257417 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04257417 |
| 15 | detection of other organism (GO:0098543) | 4.04251491 |
| 16 | detection of bacterium (GO:0016045) | 3.93787876 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87249630 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78285242 |
| 19 | viral transcription (GO:0019083) | 3.77188491 |
| 20 | regulation of mast cell degranulation (GO:0043304) | 3.63316847 |
| 21 | translational termination (GO:0006415) | 3.62302205 |
| 22 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.53775072 |
| 23 | regulation of leukocyte degranulation (GO:0043300) | 3.50934869 |
| 24 | muscle filament sliding (GO:0030049) | 3.42340609 |
| 25 | actin-myosin filament sliding (GO:0033275) | 3.42340609 |
| 26 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.38068234 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 3.33419393 |
| 28 | negative regulation of phagocytosis (GO:0050765) | 3.32094824 |
| 29 | * pinocytosis (GO:0006907) | 3.28190351 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.25466914 |
| 31 | leukocyte aggregation (GO:0070486) | 3.24435918 |
| 32 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22273307 |
| 33 | translational elongation (GO:0006414) | 3.18848877 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.18152182 |
| 35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17554512 |
| 36 | myeloid dendritic cell activation (GO:0001773) | 3.16404615 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.15822827 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 3.13622760 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.13351783 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.12923008 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.10269109 |
| 42 | cellular response to zinc ion (GO:0071294) | 3.09040875 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 3.05771207 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.05584023 |
| 45 | response to fungus (GO:0009620) | 3.04498187 |
| 46 | protein targeting to ER (GO:0045047) | 3.03715353 |
| 47 | negative regulation of necroptotic process (GO:0060546) | 3.02350723 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.01831296 |
| 49 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.01546619 |
| 50 | regulation of growth of symbiont in host (GO:0044126) | 3.01546619 |
| 51 | negative regulation of growth of symbiont in host (GO:0044130) | 3.01546619 |
| 52 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.01546619 |
| 53 | respiratory burst (GO:0045730) | 3.00937395 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99658236 |
| 55 | response to host immune response (GO:0052572) | 2.99658236 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 2.98464493 |
| 57 | myeloid dendritic cell differentiation (GO:0043011) | 2.98300170 |
| 58 | response to peptidoglycan (GO:0032494) | 2.96631092 |
| 59 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.94545976 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94268292 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.92415723 |
| 62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90961650 |
| 63 | detection of biotic stimulus (GO:0009595) | 2.90124247 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89453255 |
| 65 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89381296 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.87450070 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 2.86659297 |
| 68 | viral life cycle (GO:0019058) | 2.85328354 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83942813 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83575526 |
| 71 | DNA deamination (GO:0045006) | 2.83311733 |
| 72 | protein localization to endoplasmic reticulum (GO:0070972) | 2.83220457 |
| 73 | translational initiation (GO:0006413) | 2.82484773 |
| 74 | response to protozoan (GO:0001562) | 2.81099328 |
| 75 | B cell mediated immunity (GO:0019724) | 2.81083215 |
| 76 | IMP metabolic process (GO:0046040) | 2.80809074 |
| 77 | response to host (GO:0075136) | 2.80760588 |
| 78 | response to host defenses (GO:0052200) | 2.80760588 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.80760588 |
| 80 | cellular hyperosmotic response (GO:0071474) | 2.80633440 |
| 81 | regulation of superoxide anion generation (GO:0032928) | 2.80479425 |
| 82 | leukocyte degranulation (GO:0043299) | 2.78477998 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77569251 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.76615775 |
| 85 | defense response to protozoan (GO:0042832) | 2.76326608 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75685013 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.75428294 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.74330710 |
| 89 | IMP biosynthetic process (GO:0006188) | 2.73313725 |
| 90 | barbed-end actin filament capping (GO:0051016) | 2.71540711 |
| 91 | regulation of necrotic cell death (GO:0010939) | 2.71388357 |
| 92 | T cell apoptotic process (GO:0070231) | 2.71052139 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.70345861 |
| 94 | germinal center formation (GO:0002467) | 2.70058231 |
| 95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70056989 |
| 96 | negative thymic T cell selection (GO:0045060) | 2.70029865 |
| 97 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69957749 |
| 98 | positive regulation of mast cell degranulation (GO:0043306) | 2.69957749 |
| 99 | dendritic cell differentiation (GO:0097028) | 2.69910612 |
| 100 | cellular protein complex disassembly (GO:0043624) | 2.68196298 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 2.66100210 |
| 102 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.64717111 |
| 103 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.63451425 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 2.62580468 |
| 105 | response to interferon-beta (GO:0035456) | 2.61971751 |
| 106 | defense response to fungus (GO:0050832) | 2.61966599 |
| 107 | positive regulation of isotype switching (GO:0045830) | 2.61435923 |
| 108 | leukocyte mediated cytotoxicity (GO:0001909) | 2.61228553 |
| 109 | regulation of B cell differentiation (GO:0045577) | 2.61085737 |
| 110 | regulation of hypersensitivity (GO:0002883) | 2.58837801 |
| 111 | interferon-gamma production (GO:0032609) | 2.58815518 |
| 112 | heart process (GO:0003015) | 2.58586882 |
| 113 | heart contraction (GO:0060047) | 2.58586882 |
| 114 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58292809 |
| 115 | negative T cell selection (GO:0043383) | 2.57795218 |
| 116 | formation of translation preinitiation complex (GO:0001731) | 2.57680953 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57204334 |
| 118 | neutrophil activation (GO:0042119) | 2.56266440 |
| 119 | actin-mediated cell contraction (GO:0070252) | 2.53758327 |
| 120 | regulation of necroptotic process (GO:0060544) | 2.52922979 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.52244727 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51585058 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.50970381 |
| 124 | macrophage differentiation (GO:0030225) | 2.50605087 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.49606381 |
| 126 | granulocyte activation (GO:0036230) | 2.48820274 |
| 127 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.48542851 |
| 128 | NADPH regeneration (GO:0006740) | 2.48307106 |
| 129 | negative regulation of innate immune response (GO:0045824) | 2.47980568 |
| 130 | macrophage activation (GO:0042116) | 2.47887626 |
| 131 | tolerance induction (GO:0002507) | 2.46834950 |
| 132 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.46249706 |
| 133 | regulation of T cell tolerance induction (GO:0002664) | 2.46201863 |
| 134 | response to type I interferon (GO:0034340) | 2.46090047 |
| 135 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46009262 |
| 136 | positive thymic T cell selection (GO:0045059) | 2.45753162 |
| 137 | cellular response to type I interferon (GO:0071357) | 2.44720446 |
| 138 | type I interferon signaling pathway (GO:0060337) | 2.44720446 |
| 139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.44716650 |
| 140 | mature B cell differentiation involved in immune response (GO:0002313) | 2.44008459 |
| 141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43777110 |
| 142 | T cell migration (GO:0072678) | 2.43551062 |
| 143 | definitive hemopoiesis (GO:0060216) | 2.42897644 |
| 144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42896220 |
| 145 | positive regulation of antigen processing and presentation (GO:0002579) | 2.42871928 |
| 146 | actin nucleation (GO:0045010) | 2.42847533 |
| 147 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.42482023 |
| 148 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.42393503 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.42128117 |
| 150 | lymphocyte apoptotic process (GO:0070227) | 2.41577028 |
| 151 | positive regulation of B cell mediated immunity (GO:0002714) | 2.40982521 |
| 152 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.40982521 |
| 153 | positive regulation of leukocyte degranulation (GO:0043302) | 2.40332618 |
| 154 | ribosomal large subunit biogenesis (GO:0042273) | 2.40107452 |
| 155 | pentose-phosphate shunt (GO:0006098) | 2.40052990 |
| 156 | DNA unwinding involved in DNA replication (GO:0006268) | 2.39980167 |
| 157 | thymic T cell selection (GO:0045061) | 2.39513705 |
| 158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.38524375 |
| 159 | T cell homeostasis (GO:0043029) | 2.38457314 |
| 160 | protein complex disassembly (GO:0043241) | 2.38027103 |
| 161 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.37073482 |
| 162 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36954471 |
| 163 | myeloid leukocyte mediated immunity (GO:0002444) | 2.36440027 |
| 164 | mast cell activation (GO:0045576) | 2.35951325 |
| 165 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35610053 |
| 166 | hepatocyte apoptotic process (GO:0097284) | 2.34817193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.51110648 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.25074124 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10644239 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97026175 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95204943 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83571989 |
| 7 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72986378 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65532988 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.60982747 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.57377616 |
| 11 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52685689 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52042076 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41194776 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.39126563 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34896411 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32656445 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25903560 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22682873 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10662299 |
| 20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08685412 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.08440166 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05925104 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00711857 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00691257 |
| 25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96963673 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94439166 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.92942693 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92771475 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90876732 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.88517987 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87224011 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85079229 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84535636 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.81851308 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81508009 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81097180 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78891370 |
| 38 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78391972 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73691436 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.70837661 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70213940 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69601554 |
| 43 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.69405726 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66825379 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64611153 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62155004 |
| 47 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.61495535 |
| 48 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55922884 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.53665586 |
| 50 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53291138 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50785483 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.47821770 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46309433 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.41382430 |
| 55 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40941150 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40888815 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40805892 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40086857 |
| 59 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37607764 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36939989 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36912064 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33287974 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32990531 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32727706 |
| 65 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31969233 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31185796 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30653613 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29610753 |
| 69 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28014836 |
| 70 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27654752 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25448959 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.24720268 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24628252 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23668734 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23613399 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22840424 |
| 77 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22048126 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21740754 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21373277 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20377039 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18941060 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18641731 |
| 83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18399824 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17545680 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16276217 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15699499 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15677136 |
| 88 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15674270 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15559690 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14213617 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14201647 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12246422 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11827524 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11637535 |
| 95 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11423334 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11383703 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11129986 |
| 98 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10204189 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10138562 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10053223 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09690137 |
| 102 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09323240 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08748217 |
| 104 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06080261 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05424642 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05305322 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04617480 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 1.04084323 |
| 109 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03582526 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03146971 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01273050 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00085111 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98358300 |
| 114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98157206 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98091593 |
| 116 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97742516 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97733730 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97593095 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97322008 |
| 120 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96943502 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96840753 |
| 122 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95728146 |
| 123 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95636509 |
| 124 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94404769 |
| 125 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93598772 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92923147 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92703618 |
| 128 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91717613 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90254904 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88011051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.50812030 |
| 2 | MP0003436_decreased_susceptibility_to | 3.24886031 |
| 3 | MP0000685_abnormal_immune_system | 2.89343246 |
| 4 | MP0005451_abnormal_body_composition | 2.84970853 |
| 5 | MP0009785_altered_susceptibility_to | 2.82962016 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.70124313 |
| 7 | MP0005671_abnormal_response_to | 2.69934504 |
| 8 | MP0003303_peritoneal_inflammation | 2.52773716 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.50900898 |
| 10 | MP0005025_abnormal_response_to | 2.50502859 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.49155356 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.48247408 |
| 13 | MP0001800_abnormal_humoral_immune | 2.35511280 |
| 14 | MP0002419_abnormal_innate_immunity | 2.30610500 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.30378472 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.22549767 |
| 17 | MP0005387_immune_system_phenotype | 2.20671073 |
| 18 | MP0001790_abnormal_immune_system | 2.20671073 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.18024396 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.16757011 |
| 21 | MP0002723_abnormal_immune_serum | 2.16707347 |
| 22 | MP0001819_abnormal_immune_cell | 2.15870310 |
| 23 | MP0001853_heart_inflammation | 2.13382738 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.07813072 |
| 25 | MP0002398_abnormal_bone_marrow | 2.06604005 |
| 26 | MP0008260_abnormal_autophagy | 2.06456284 |
| 27 | MP0002405_respiratory_system_inflammati | 2.06246097 |
| 28 | MP0001545_abnormal_hematopoietic_system | 2.04793934 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 2.04793934 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.04239511 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 2.02897574 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.98242109 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.97871624 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.97618465 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.94767124 |
| 36 | MP0000490_abnormal_crypts_of | 1.94619991 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.91267419 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.86403799 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.86307752 |
| 40 | MP0000716_abnormal_immune_system | 1.85467021 |
| 41 | MP0005330_cardiomyopathy | 1.83151463 |
| 42 | MP0008057_abnormal_DNA_replication | 1.82875130 |
| 43 | MP0002722_abnormal_immune_system | 1.79552842 |
| 44 | MP0004947_skin_inflammation | 1.79259745 |
| 45 | MP0002006_tumorigenesis | 1.78658107 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.78413127 |
| 47 | MP0003724_increased_susceptibility_to | 1.77558963 |
| 48 | MP0000751_myopathy | 1.77527260 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.72798134 |
| 50 | MP0001873_stomach_inflammation | 1.69981078 |
| 51 | MP0002429_abnormal_blood_cell | 1.65330375 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.61411804 |
| 53 | MP0000858_altered_metastatic_potential | 1.59397857 |
| 54 | MP0006082_CNS_inflammation | 1.53231382 |
| 55 | MP0003866_abnormal_defecation | 1.53088365 |
| 56 | MP0003646_muscle_fatigue | 1.52752207 |
| 57 | MP0009278_abnormal_bone_marrow | 1.50994706 |
| 58 | MP0000749_muscle_degeneration | 1.44971024 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.44398602 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.44092372 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.40887889 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.39494254 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.39358452 |
| 64 | MP0004087_abnormal_muscle_fiber | 1.34163589 |
| 65 | MP0003077_abnormal_cell_cycle | 1.32951717 |
| 66 | MP0010307_abnormal_tumor_latency | 1.32934572 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.32931225 |
| 68 | MP0003656_abnormal_erythrocyte_physiolo | 1.30776152 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.29652926 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25687141 |
| 71 | MP0003448_altered_tumor_morphology | 1.25671588 |
| 72 | MP0003111_abnormal_nucleus_morphology | 1.24695027 |
| 73 | MP0000343_altered_response_to | 1.23021307 |
| 74 | MP0004510_myositis | 1.22790158 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.19335479 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.18364871 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.18270062 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.18139334 |
| 79 | MP0005165_increased_susceptibility_to | 1.18024678 |
| 80 | MP0010630_abnormal_cardiac_muscle | 1.17395806 |
| 81 | MP0008469_abnormal_protein_level | 1.15298131 |
| 82 | MP0003172_abnormal_lysosome_physiology | 1.14133291 |
| 83 | MP0000747_muscle_weakness | 1.10512681 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.08856573 |
| 85 | MP0002972_abnormal_cardiac_muscle | 1.08643515 |
| 86 | MP0008007_abnormal_cellular_replicative | 1.08304329 |
| 87 | MP0001851_eye_inflammation | 1.08214131 |
| 88 | MP0004233_abnormal_muscle_weight | 1.06209061 |
| 89 | MP0002269_muscular_atrophy | 1.05778864 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.05677306 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 1.05444551 |
| 92 | MP0005310_abnormal_salivary_gland | 1.04420991 |
| 93 | MP0002332_abnormal_exercise_endurance | 1.03258377 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 1.01599013 |
| 95 | MP0000750_abnormal_muscle_regeneration | 1.00582223 |
| 96 | MP0009840_abnormal_foam_cell | 0.97381997 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.97253527 |
| 98 | MP0000759_abnormal_skeletal_muscle | 0.97211677 |
| 99 | MP0008004_abnormal_stomach_pH | 0.97209928 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.96059013 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.95115950 |
| 102 | MP0005023_abnormal_wound_healing | 0.94780355 |
| 103 | MP0005166_decreased_susceptibility_to | 0.94227846 |
| 104 | MP0009764_decreased_sensitivity_to | 0.92981334 |
| 105 | MP0004130_abnormal_muscle_cell | 0.92710933 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.91280238 |
| 107 | MP0006138_congestive_heart_failure | 0.90470458 |
| 108 | MP0001849_ear_inflammation | 0.87346094 |
| 109 | MP0002132_abnormal_respiratory_system | 0.87262040 |
| 110 | MP0002933_joint_inflammation | 0.86891156 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.86357818 |
| 112 | MP0005385_cardiovascular_system_phenoty | 0.86357818 |
| 113 | MP0008058_abnormal_DNA_repair | 0.85916074 |
| 114 | MP0002106_abnormal_muscle_physiology | 0.85411507 |
| 115 | MP0003828_pulmonary_edema | 0.84910793 |
| 116 | MP0000313_abnormal_cell_death | 0.84054010 |
| 117 | MP0000604_amyloidosis | 0.83596778 |
| 118 | MP0004484_altered_response_of | 0.83523239 |
| 119 | MP0004215_abnormal_myocardial_fiber | 0.82354549 |
| 120 | MP0002254_reproductive_system_inflammat | 0.82093562 |
| 121 | MP0002796_impaired_skin_barrier | 0.81594529 |
| 122 | MP0003705_abnormal_hypodermis_morpholog | 0.79662521 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.77677068 |
| 124 | MP0009763_increased_sensitivity_to | 0.74960271 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.74946130 |
| 126 | MP0002095_abnormal_skin_pigmentation | 0.74036691 |
| 127 | MP0009931_abnormal_skin_appearance | 0.72847650 |
| 128 | MP0006054_spinal_hemorrhage | 0.69726371 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.69642031 |
| 130 | MP0000371_diluted_coat_color | 0.69510226 |
| 131 | MP0003186_abnormal_redox_activity | 0.68883850 |
| 132 | MP0005501_abnormal_skin_physiology | 0.68218531 |
| 133 | MP0001663_abnormal_digestive_system | 0.68089338 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.65340449 |
| 135 | MP0001348_abnormal_lacrimal_gland | 0.64210941 |
| 136 | MP0003075_altered_response_to | 0.62482104 |
| 137 | MP0001191_abnormal_skin_condition | 0.61904745 |
| 138 | MP0005390_skeleton_phenotype | 0.59724043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.36510063 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.03940506 |
| 3 | Thrombocytosis (HP:0001894) | 4.74391844 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.67713394 |
| 5 | Myositis (HP:0100614) | 4.51638868 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.23515606 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.99230455 |
| 8 | IgM deficiency (HP:0002850) | 3.75597556 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.56794041 |
| 10 | Chronic otitis media (HP:0000389) | 3.55258722 |
| 11 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.54181038 |
| 12 | Petechiae (HP:0000967) | 3.54088180 |
| 13 | Orchitis (HP:0100796) | 3.52818170 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.50374604 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.50334368 |
| 16 | Recurrent viral infections (HP:0004429) | 3.41812767 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 3.38995421 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38845752 |
| 19 | Obstructive lung disease (HP:0006536) | 3.38845752 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.38669382 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.36283557 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.31602398 |
| 23 | Sudden death (HP:0001699) | 3.30682401 |
| 24 | Ragged-red muscle fibers (HP:0003200) | 3.28391725 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23203316 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23203316 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22272066 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.22268012 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.22268012 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.22268012 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.17345763 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.16958348 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.15700655 |
| 34 | Muscle fiber inclusion bodies (HP:0100299) | 3.15082768 |
| 35 | Recurrent skin infections (HP:0001581) | 3.14748980 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.13103989 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.06219785 |
| 38 | Nemaline bodies (HP:0003798) | 3.04378729 |
| 39 | Reticulocytopenia (HP:0001896) | 3.02472371 |
| 40 | Pustule (HP:0200039) | 3.01316808 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94577371 |
| 42 | Increased IgE level (HP:0003212) | 2.91680574 |
| 43 | Abnormality of T cells (HP:0002843) | 2.91594956 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.91352800 |
| 45 | Optic neuritis (HP:0100653) | 2.91352800 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.90978297 |
| 47 | Meningitis (HP:0001287) | 2.90943271 |
| 48 | Vasculitis (HP:0002633) | 2.88924227 |
| 49 | Stomatitis (HP:0010280) | 2.88064862 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.86850188 |
| 51 | Cellulitis (HP:0100658) | 2.84338851 |
| 52 | EMG: myopathic abnormalities (HP:0003458) | 2.83677176 |
| 53 | Chest pain (HP:0100749) | 2.77209470 |
| 54 | Increased connective tissue (HP:0009025) | 2.75430766 |
| 55 | Nasal polyposis (HP:0100582) | 2.74322541 |
| 56 | Periodontitis (HP:0000704) | 2.67929566 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.64139484 |
| 58 | Epistaxis (HP:0000421) | 2.63825828 |
| 59 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.63576889 |
| 60 | Fatigue (HP:0012378) | 2.60123016 |
| 61 | Myoglobinuria (HP:0002913) | 2.59775398 |
| 62 | Hemoptysis (HP:0002105) | 2.59603665 |
| 63 | Leukocytosis (HP:0001974) | 2.58829432 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.57533989 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.56922698 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.56642862 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.56161757 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.55514078 |
| 69 | Amyloidosis (HP:0011034) | 2.55193288 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 2.52320858 |
| 71 | Abnormal platelet function (HP:0011869) | 2.51368274 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.51368274 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.50672572 |
| 74 | Inflammation of the large intestine (HP:0002037) | 2.50237150 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.49714211 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.49541822 |
| 77 | Arterial thrombosis (HP:0004420) | 2.47915524 |
| 78 | Amaurosis fugax (HP:0100576) | 2.47585431 |
| 79 | Progressive muscle weakness (HP:0003323) | 2.43052371 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.42490738 |
| 81 | Granulocytopenia (HP:0001913) | 2.40353658 |
| 82 | Pallor (HP:0000980) | 2.37847171 |
| 83 | Aplastic anemia (HP:0001915) | 2.37529559 |
| 84 | Skin ulcer (HP:0200042) | 2.36866277 |
| 85 | Gingivitis (HP:0000230) | 2.35291625 |
| 86 | Increased serum ferritin (HP:0003281) | 2.33158587 |
| 87 | Eosinophilia (HP:0001880) | 2.29312541 |
| 88 | Right ventricular cardiomyopathy (HP:0011663) | 2.28167623 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.27995196 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26983215 |
| 91 | Abnormality of T cell number (HP:0011839) | 2.26128875 |
| 92 | Poikiloderma (HP:0001029) | 2.25541495 |
| 93 | Agnosia (HP:0010524) | 2.24819753 |
| 94 | Lymphopenia (HP:0001888) | 2.24118614 |
| 95 | Gangrene (HP:0100758) | 2.23831962 |
| 96 | Lipoatrophy (HP:0100578) | 2.23657452 |
| 97 | Dilated cardiomyopathy (HP:0001644) | 2.22699204 |
| 98 | T lymphocytopenia (HP:0005403) | 2.21734925 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 2.19869274 |
| 100 | Gastrointestinal infarctions (HP:0005244) | 2.19653527 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.19307091 |
| 102 | Exercise-induced muscle cramps (HP:0003710) | 2.19151892 |
| 103 | Abnormality of B cell number (HP:0010975) | 2.18974960 |
| 104 | B lymphocytopenia (HP:0010976) | 2.18974960 |
| 105 | Cheilitis (HP:0100825) | 2.18256210 |
| 106 | Urticaria (HP:0001025) | 2.17432950 |
| 107 | Neck muscle weakness (HP:0000467) | 2.17090360 |
| 108 | Loss of speech (HP:0002371) | 2.15909146 |
| 109 | IgA deficiency (HP:0002720) | 2.15880118 |
| 110 | Upper motor neuron abnormality (HP:0002127) | 2.15391284 |
| 111 | Gingival bleeding (HP:0000225) | 2.14382984 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.13851379 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.13237959 |
| 114 | Purpura (HP:0000979) | 2.11982370 |
| 115 | Subaortic stenosis (HP:0001682) | 2.11947007 |
| 116 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11947007 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 2.11935189 |
| 118 | Lymphoma (HP:0002665) | 2.11448369 |
| 119 | Acute myeloid leukemia (HP:0004808) | 2.10517503 |
| 120 | Abnormality of eosinophils (HP:0001879) | 2.09941955 |
| 121 | IgG deficiency (HP:0004315) | 2.08693742 |
| 122 | Keratoconjunctivitis (HP:0001096) | 2.08372037 |
| 123 | Osteomyelitis (HP:0002754) | 2.02903153 |
| 124 | Myopathic facies (HP:0002058) | 2.02751030 |
| 125 | Bulbar palsy (HP:0001283) | 2.01625328 |
| 126 | Bundle branch block (HP:0011710) | 2.01094632 |
| 127 | Encephalitis (HP:0002383) | 2.00247373 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.99436921 |
| 129 | Colitis (HP:0002583) | 1.97642452 |
| 130 | Myelodysplasia (HP:0002863) | 1.97528470 |
| 131 | Difficulty running (HP:0009046) | 1.96284489 |
| 132 | Abnormality of the endocardium (HP:0004306) | 1.94569942 |
| 133 | Muscle stiffness (HP:0003552) | 1.93974729 |
| 134 | Erythema (HP:0010783) | 1.89287057 |
| 135 | Pulmonary fibrosis (HP:0002206) | 1.88529730 |
| 136 | Agammaglobulinemia (HP:0004432) | 1.87842135 |
| 137 | Difficulty climbing stairs (HP:0003551) | 1.87376118 |
| 138 | Increased density of long bones (HP:0006392) | 1.86168385 |
| 139 | Abnormal platelet volume (HP:0011876) | 1.85329031 |
| 140 | Ventricular arrhythmia (HP:0004308) | 1.85295001 |
| 141 | Thoracic kyphosis (HP:0002942) | 1.85172825 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.84413661 |
| 143 | Increased IgM level (HP:0003496) | 1.79270987 |
| 144 | Restrictive lung disease (HP:0002091) | 1.78102322 |
| 145 | Leukopenia (HP:0001882) | 1.77288153 |
| 146 | Basal ganglia calcification (HP:0002135) | 1.77100070 |
| 147 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75911767 |
| 148 | Albinism (HP:0001022) | 1.75570856 |
| 149 | Macrocytic anemia (HP:0001972) | 1.75138189 |
| 150 | Increased cerebral lipofuscin (HP:0011813) | 1.74878633 |
| 151 | Neutropenia (HP:0001875) | 1.74659840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.72412236 |
| 2 | PRPF4B | 3.07220561 |
| 3 | PIM2 | 2.56364925 |
| 4 | EEF2K | 2.54436391 |
| 5 | TXK | 2.46656618 |
| 6 | JAK3 | 2.41831641 |
| 7 | BLK | 2.23807809 |
| 8 | TEC | 2.22340108 |
| 9 | BTK | 2.21336898 |
| 10 | IRAK4 | 2.20250964 |
| 11 | ZAP70 | 2.16829950 |
| 12 | NME2 | 2.16470217 |
| 13 | MAP3K14 | 2.14832351 |
| 14 | MAP2K3 | 2.11338536 |
| 15 | ERN1 | 2.10411473 |
| 16 | TYK2 | 1.98509877 |
| 17 | KIT | 1.94104549 |
| 18 | TBK1 | 1.93611721 |
| 19 | PKN2 | 1.88103348 |
| 20 | STK10 | 1.83403996 |
| 21 | OBSCN | 1.75745362 |
| 22 | RPS6KA4 | 1.70338073 |
| 23 | ITK | 1.64291092 |
| 24 | LRRK2 | 1.64124064 |
| 25 | SMG1 | 1.59920004 |
| 26 | IKBKB | 1.53135197 |
| 27 | FLT3 | 1.50639771 |
| 28 | TAOK3 | 1.48043528 |
| 29 | IKBKE | 1.47678705 |
| 30 | RPS6KB2 | 1.45253087 |
| 31 | SYK | 1.41205110 |
| 32 | PIM1 | 1.38592953 |
| 33 | TRIB3 | 1.35856111 |
| 34 | MAP3K6 | 1.33932901 |
| 35 | IRAK3 | 1.31021664 |
| 36 | MAP3K11 | 1.27261790 |
| 37 | WEE1 | 1.24998680 |
| 38 | HCK | 1.19781726 |
| 39 | MAP3K3 | 1.18970439 |
| 40 | SCYL2 | 1.18869973 |
| 41 | TGFBR1 | 1.17537486 |
| 42 | TNK2 | 1.15965763 |
| 43 | BCKDK | 1.15049442 |
| 44 | MAP3K1 | 1.14013205 |
| 45 | MAPKAPK3 | 1.11900103 |
| 46 | EPHB1 | 1.09330352 |
| 47 | MOS | 1.08993565 |
| 48 | RIPK4 | 1.08967929 |
| 49 | LCK | 1.06999133 |
| 50 | NEK2 | 1.05250243 |
| 51 | GRK6 | 1.04357691 |
| 52 | MAPK12 | 1.02534232 |
| 53 | CHUK | 1.02320098 |
| 54 | TTN | 1.01723555 |
| 55 | CDC42BPA | 1.01471043 |
| 56 | CDK12 | 1.00593506 |
| 57 | KSR2 | 1.00317185 |
| 58 | CSF1R | 1.00011850 |
| 59 | JAK1 | 0.98151606 |
| 60 | DYRK3 | 0.95884576 |
| 61 | ARAF | 0.95772124 |
| 62 | FES | 0.88413732 |
| 63 | EIF2AK3 | 0.88127274 |
| 64 | MAP3K8 | 0.87226471 |
| 65 | EIF2AK1 | 0.87224466 |
| 66 | TRPM7 | 0.86137415 |
| 67 | CDK4 | 0.85056198 |
| 68 | MATK | 0.84362771 |
| 69 | CDC7 | 0.83401845 |
| 70 | TESK2 | 0.83187335 |
| 71 | LYN | 0.83072204 |
| 72 | RIPK1 | 0.81675846 |
| 73 | DMPK | 0.80425593 |
| 74 | CSK | 0.80360303 |
| 75 | CDK6 | 0.79168524 |
| 76 | TGFBR2 | 0.78782124 |
| 77 | FGR | 0.76875434 |
| 78 | CLK1 | 0.76487104 |
| 79 | JAK2 | 0.76440190 |
| 80 | IRAK2 | 0.76200517 |
| 81 | ICK | 0.75155016 |
| 82 | FGFR4 | 0.75035155 |
| 83 | MAP3K10 | 0.74486678 |
| 84 | PAK4 | 0.74161824 |
| 85 | VRK2 | 0.72574510 |
| 86 | PDPK1 | 0.71617612 |
| 87 | CDK7 | 0.70797564 |
| 88 | MST4 | 0.69254131 |
| 89 | TSSK6 | 0.68138915 |
| 90 | ATR | 0.67185525 |
| 91 | TAOK1 | 0.65848461 |
| 92 | STK4 | 0.65670125 |
| 93 | PRKD2 | 0.65473832 |
| 94 | KDR | 0.65289746 |
| 95 | NLK | 0.64046431 |
| 96 | GRK7 | 0.63580341 |
| 97 | MARK3 | 0.63347346 |
| 98 | MAPKAPK2 | 0.62992314 |
| 99 | RAF1 | 0.62802433 |
| 100 | TESK1 | 0.62582697 |
| 101 | PTK6 | 0.60830691 |
| 102 | MARK2 | 0.60535658 |
| 103 | FGFR3 | 0.59863708 |
| 104 | PIK3CG | 0.59501691 |
| 105 | PASK | 0.59215187 |
| 106 | MAP3K13 | 0.58339115 |
| 107 | PDK1 | 0.57297055 |
| 108 | TAOK2 | 0.56215909 |
| 109 | STK16 | 0.56038008 |
| 110 | ALK | 0.55617129 |
| 111 | ABL2 | 0.54434173 |
| 112 | MAP3K7 | 0.54212912 |
| 113 | RPS6KA6 | 0.52984902 |
| 114 | BRSK2 | 0.52491451 |
| 115 | STK24 | 0.52115390 |
| 116 | MAP3K5 | 0.51741224 |
| 117 | EPHA3 | 0.50511573 |
| 118 | ACVR1B | 0.50440952 |
| 119 | SIK1 | 0.50112160 |
| 120 | AURKB | 0.49998177 |
| 121 | BUB1 | 0.49747986 |
| 122 | MAPK11 | 0.48778684 |
| 123 | HIPK2 | 0.45461626 |
| 124 | IRAK1 | 0.44605269 |
| 125 | DAPK3 | 0.44492837 |
| 126 | PRKD1 | 0.43834077 |
| 127 | RPS6KA1 | 0.43788530 |
| 128 | RPS6KC1 | 0.43601953 |
| 129 | RPS6KL1 | 0.43601953 |
| 130 | MAPK4 | 0.41182031 |
| 131 | CDK19 | 0.40832430 |
| 132 | NEK9 | 0.40534787 |
| 133 | BMX | 0.40224528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.77169292 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.70467811 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57245778 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28994013 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18012828 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12639399 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.09091789 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00575304 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.99503232 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.98748558 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.94841322 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.92023262 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82172500 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.78892293 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77456839 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76076749 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.72586671 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.69471197 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67617105 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67180821 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59593869 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.54259234 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51969770 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50652920 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48549836 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46338908 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45420896 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43335001 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40761677 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.37700230 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.35079855 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32235865 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29898161 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.29381936 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28981269 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.26419510 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25461179 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.24706544 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.24424207 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.22935823 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22404258 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.18352411 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.17521630 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15545659 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14896119 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14257903 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13789355 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.11753589 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11383172 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09284238 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.09061735 |
| 52 | RNA transport_Homo sapiens_hsa03013 | 1.08877711 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07480641 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07346414 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06791896 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05738585 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 1.05342770 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04193918 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03567144 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02868808 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01078795 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99716662 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.99445469 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98325083 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.95682622 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94582124 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.90734381 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88445427 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.88425579 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88393672 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88322247 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88036792 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86963620 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86294605 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.86160045 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83273474 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.82021569 |
| 78 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81901908 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81745142 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80280449 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74518172 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.73414809 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71893262 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.71332585 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.71303826 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.68927796 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68435143 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68268714 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65643834 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64548616 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64087063 |
| 92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63165516 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62161830 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61922436 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61219993 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60993137 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60645212 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60182094 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55016672 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54344109 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.53559874 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53038996 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51648372 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51454111 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.51244505 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50589986 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50467279 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47605963 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47601937 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47394459 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45530200 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44531015 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43956224 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43925956 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43704334 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42858573 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41824211 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41691325 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41223675 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40786068 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39588274 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39042155 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38979769 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37718787 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37429647 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.37039076 |
| 127 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.36706460 |

